Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
<p>Abstract</p> <p>Background</p> <p>Statins are a class of medications that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Whether statins can benefit patients with dementia remains unclear because of conflicting results. We hypothesi...
Main Authors: | Li Nien-Chen, Wang Stanley W, Wolozin Benjamin, Lee Austin, Lee Todd A, Kazis Lewis E |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-07-01
|
Series: | BMC Medicine |
Online Access: | http://www.biomedcentral.com/1741-7015/5/20 |
Similar Items
-
Beneficial association of angiotensin-converting enzyme inhibitors and statins on the occurrence of possible Alzheimer’s disease after traumatic brain injury
by: Mingfei Li, et al.
Published: (2020-03-01) -
Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
by: Alessandra Nicoletti, et al.
Published: (2019-02-01) -
Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
by: Priyadarshi Prajjwal, et al.
Published: (2024-04-01) -
Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are Associated with Increased Caregiver Burden
by: Yoon-Sang Oh, et al.
Published: (2015-01-01) -
Serum zinc deficiency could be associated with dementia conversion in Parkinson’s disease
by: Jieun Lee, et al.
Published: (2023-04-01)